IL6 and COVID-19: Consequently, cytokines, including interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), have shown potential prognostic value to guide decisions on clinical management of COVID-19 (refs. 7,8), but they lack adequate specificity.